ADD/ADHD News

Diagnoses of psychiatric disorders were associated with increased incidence of COVID-19 breakthrough infection in VA patients, with the strongest associations found in older patients, according to a study published in JAMA Network Open.

The American Psychiatric Association on Wednesday announced the launch of PsychPRO 2.0, a mental health registry that offers psychiatrists enhanced options to engage with patients, track outcomes and streamline data for quality reporting.

Healio’s most-viewed psychiatry stories in February highlight a study on antidepressant combination therapies, updates in ADHD treatments and the pandemic’s impact on those with mood and anxiety disorders.

A genomic approach may help identify children at high risk for suicidal thoughts and behaviors, according to results of a cohort study published in JAMA Network Open.

Prevalence of mental disorders among first- and second-generation immigrant and refugee children and youth was generally lower relative to similar populations of nonimmigrants, per a Canadian cohort study published in JAMA Network Open.

The FDA has granted approval to late-stage biotech company Neurocentria Inc. to conduct a pivotal phase 2b/3 human clinical trial of its drug candidate NRCT-101SR compared with inactive placebo among adults with ADHD.

Children with ADHD exhibited modest differences on structural brain measures compared with peers without ADHD, according to results of a cross-sectional population-based study published in The Lancet Psychiatry.

A study found statistically significant improvement in ADHD symptoms in children who wore the Revibe Connect device to school, according to a press release.

Children born to mothers with active eating disorders during pregnancy demonstrated an elevated risk for developing ADHD and autism spectrum disorders, according to a Swedish population-based cohort study published in JAMA Network Open.

The prevalence of mental disorders has been on the rise and remains a significant leading cause of disease burden worldwide, according to a 30-year global systematic analysis published in The Lancet Psychiatry.